ResMed Inc. (RMD)
NYSE: RMD · Real-Time Price · USD
285.58
-2.10 (-0.73%)
Aug 14, 2025, 12:01 PM - Market open

Company Description

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally.

The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution.

The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients’ device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between our compatible ventilation devices and AirView system.

In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers.

ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

ResMed Inc.
ResMed logo
CountryUnited States
Founded1989
IPO DateJun 2, 1995
IndustryMedical Instruments & Supplies
SectorHealthcare
Employees9,980
CEOMichael Farrell

Contact Details

Address:
9001 Spectrum Center Boulevard
San Diego, California 92123
United States
Phone858-836-5000
Websiteresmed.co.in

Stock Details

Ticker SymbolRMD
ExchangeNYSE
Stock TypeCommon Stock
Fiscal YearJuly - June
Reporting CurrencyUSD
CIK Code0000943819
CUSIP Number761152107
ISIN NumberUS7611521078
Employer ID98-0152841
SIC Code3841

Key Executives

NamePosition
Michael J. Farrell BE, MBA, SMChief Executive Officer and Chairman
Dr. Peter C. Farrell A.M., B.E., BE (Hons), Ph.D., ScDFounder, Chair Emeritus and Director
Brett A. SandercockChief Financial Officer
Michael J. RiderChief Legal Officer and Secretary
Justin LeongChief Product Officer
Alastair RobertsonChief Information Officer
Sallilyn SchwartzChief Investor Relations Officer
Jim EllisChief Compliance Officer
Yvonne-Katrin PucknatChief Marketing Officer
Vered KeisarChief People Officer

Latest SEC Filings

DateTypeTitle
Aug 8, 202510-KAnnual Report
Aug 7, 2025144Filing
Aug 1, 2025144Filing
Aug 1, 2025144Filing
Aug 1, 20258-KCurrent Report
Jul 31, 20258-KCurrent Report
Jul 7, 2025144Filing
Jul 2, 2025144Filing
Jul 1, 2025144Filing
Jul 1, 2025144Filing